Recently Completed Studies

Our recently completed studies, include the following:

  • A Phase 3, 12-Week, Double-Blind, Placebo- and Active-Controlled Efficacy and Safety Study of Preladenant in Subjects with Moderate to Severe Parkinson’s Disease (Phase 3, Protocol No. P04938) (closed 2013)
  • A Phase 3, 40- Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects with Moderate to Severe Parkinson’s Disease (Phase 3, Protocol No. P06153) (closed 2014)
  • A Multi-Center, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the clinical effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic (closed 2013)
  • Magnetic Stimulation for the Treatment of Motor and Mood Symptoms of Parkinson’s Disease (closed May 2015)
  • Sleep and Learn with TMS in Parkinson’s disease (June 2014)